Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer.

Cell Mol Gastroenterol Hepatol · 2018 · PMC6008260 · PMID 29928669

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The treatment of mice bearing human BxPC-3 tumors with 240 nmol/L of target-specific NPs showed a decrease in final tumor weights ( Figure 4 A ) compared with untargeted and control (PBS-treated) mice, but these decreases did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.